Skip to content

ships in 24–48 h · free from €250

Peptide lexicon

Pentadeca Arginate (PDA)

Arginate salt form of a BPC-157-related pentadecapeptide, described as a more stable variant in regeneration research.

Substance classPeptide
SequenceGEPPPGKPADDAGLV (Arginatsalz)
SynonymsPDA, BPC-157-Arginat

Structure

Pentadeca Arginate (PDA) carries the same 15-amino-acid sequence as BPC-157 (GEPPPGKPADDAGLV) but as an arginate salt. Suppliers describe higher stability in solution; independent structural data are scarce.

State of research

Research questions mirror those of BPC-157: angiogenesis and tendon, muscle and gut repair in cell and animal models. Peer-reviewed studies on PDA itself are scarce.

Status

PDA is not approved as a medicinal product.

Contained in

More in the magazine

Substance profiles ·

Oral BPC-157: capsules or vial in research?

Oral BPC-157 explained: why the peptide is considered stable in gastric juice, what animal studies with oral dosing show and when capsules or lyophilised powder fit.